Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Classement en actions #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Prix de l'action
$1.50
Dernière synchronisation: 2026-09-21
Capitalisation boursière
$3.63M
Changement (1 jour)
-4.46%
Changement (1 an)
-72.68%
Pays
MY
Échange BioNexus Gene Lab Corp. (BGLC)

Catégorie

EPS pour BioNexus Gene Lab Corp. (BGLC)
EPS au June 2026 TTM : $-1.26
Selon les derniers rapports financiers et le cours de l'action de BioNexus Gene Lab Corp., l’EPS actuel de la société (TTM) est de $-1.26. À la fin de 2023, la société avait un EPS de $-1.53 une augmentation par rapport à celui de 2022, qui était de $-0.25.
Historique de l'EPS de BioNexus Gene Lab Corp. de 2016 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-1.26 40.00%
2024 $-0.90 -41.18%
2023 $-1.53 512.00%
2022 $-0.25 -147.17%
2021 $0.53 -58.59%
2020 $1.28 -3,842.69%
2019 $-0.03 -812.50%
2018 0.00 -124.12%
2017 $-0.02 19,800.00%
2016 0.00 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$39.24 -3,214.29%
US
$1.18 -193.65%
US
- -
US
$14.65 -1,262.70%
US
- -
US